Clinical Trial Update: Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease

View source ↗

Summary

A clinical trial evaluating convection-enhanced delivery of glucocerebrosidase to treat Type 2 Gaucher Disease has completed. The study status is reported as co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Gaucher Disease

Drugs mentioned

• Glucocerebrosidase (glucocerebrosidase)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Type 2 Gaucher Disease | Status: COMPLETED